Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas E Witzig

Showing results (201-210 of 387) with videos related to

Pageof 39
Sort By:
Cytokine|September 27, 2012
Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control studyBridget Charbonneau, Matthew J Maurer, Stephen M Ansell, et al.
Cancer|October 20, 2011
Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)Tait D Shanafelt, Neil E Kay, Kari G Rabe, et al.
American Journal of Hematology|April 23, 2019
Detection of extranodal and spleen involvement by FDG-PET imaging predicts adverse survival in untreated follicular lymphomaFrédérique St-Pierre, Stephen M Broski, Betsy R LaPlant, et al.
American Journal of Hematology|August 24, 2010
Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myelomaKristen Detweiler-Short, Suzanne Hayman, Morie A Gertz, et al.
Blood Cancer Journal|September 26, 2021
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E studySanjal H Desai, Betsy LaPlant, William R Macon, et al.
Leukemia & Lymphoma|June 24, 2008
Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment GroupThomas E Witzig, Susan M Geyer, Paul J Kurtin, et al.
Blood|November 29, 2002
POEMS syndrome: definitions and long-term outcomeAngela Dispenzieri, Robert A Kyle, Martha Q Lacy, et al.
Blood|January 15, 2005
Proteomic analysis of mantle-cell lymphoma by protein microarrayIrene M Ghobrial, Daniel J McCormick, Scott H Kaufmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Thymidylate synthase expression in colon carcinomas with microsatellite instabilityFrank A Sinicrope, Rafaela L Rego, Kevin C Halling, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 13, 2018
Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related DiseaseShounak Majumder, Sonmoon Mohapatra, Ryan J Lennon, et al.
Pageof 39

Showing results (201-210 of 387) with videos related to

Sort By:
Pageof 39
Cytokine|September 27, 2012
Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control studyBridget Charbonneau, Matthew J Maurer, Stephen M Ansell, et al.
Cancer|October 20, 2011
Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)Tait D Shanafelt, Neil E Kay, Kari G Rabe, et al.
American Journal of Hematology|April 23, 2019
Detection of extranodal and spleen involvement by FDG-PET imaging predicts adverse survival in untreated follicular lymphomaFrédérique St-Pierre, Stephen M Broski, Betsy R LaPlant, et al.
American Journal of Hematology|August 24, 2010
Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myelomaKristen Detweiler-Short, Suzanne Hayman, Morie A Gertz, et al.
Blood Cancer Journal|September 26, 2021
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E studySanjal H Desai, Betsy LaPlant, William R Macon, et al.
Leukemia & Lymphoma|June 24, 2008
Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment GroupThomas E Witzig, Susan M Geyer, Paul J Kurtin, et al.
Blood|November 29, 2002
POEMS syndrome: definitions and long-term outcomeAngela Dispenzieri, Robert A Kyle, Martha Q Lacy, et al.
Blood|January 15, 2005
Proteomic analysis of mantle-cell lymphoma by protein microarrayIrene M Ghobrial, Daniel J McCormick, Scott H Kaufmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Thymidylate synthase expression in colon carcinomas with microsatellite instabilityFrank A Sinicrope, Rafaela L Rego, Kevin C Halling, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 13, 2018
Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related DiseaseShounak Majumder, Sonmoon Mohapatra, Ryan J Lennon, et al.
Pageof 39